FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

841000237104: Mass concentration of carbamazepine 10,11 epoxide in serum (observable entity)


Status: current, Sufficiently defined by necessary conditions definition status. Date: 12-Apr 2023. Module: SNOMED CT United Kingdom pathology and laboratory medicine production content extension module

Descriptions:

Id Description Lang Type Status Case? Module
5821000237111 Mass concentration of carbamazepine 10,11 epoxide in serum (observable entity) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom pathology and laboratory medicine production content extension module
5951000237111 Carbamazepine 10,11 epoxide mass concentration in serum en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom pathology and laboratory medicine production content extension module


1 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Mass concentration of carbamazepine 10,11 epoxide in serum (observable entity) Is a Observable entity false Inferred relationship Existential restriction modifier
Mass concentration of carbamazepine 10,11 epoxide in serum (observable entity) Component Carbamazepine-10,11-epoxide true Inferred relationship Existential restriction modifier 1
Mass concentration of carbamazepine 10,11 epoxide in serum (observable entity) Is a Serum clinical chemistry true Inferred relationship Existential restriction modifier
Mass concentration of carbamazepine 10,11 epoxide in serum (observable entity) Is a Serum carbamazepine level true Inferred relationship Existential restriction modifier
Mass concentration of carbamazepine 10,11 epoxide in serum (observable entity) Property Mass concentration true Inferred relationship Existential restriction modifier 1
Mass concentration of carbamazepine 10,11 epoxide in serum (observable entity) Inheres in Serum true Inferred relationship Existential restriction modifier 1
Mass concentration of carbamazepine 10,11 epoxide in serum (observable entity) Direct site Serum specimen true Inferred relationship Existential restriction modifier 1

Inbound Relationships Type Active Source Characteristic Refinability Group
Mass concentration of carbamazepine epoxide in serum (observable entity) Is a True Mass concentration of carbamazepine 10,11 epoxide in serum (observable entity) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start